Royal Bank Of Canada Astrazeneca PLC Transaction History

Royal Bank Of Canada

$479 Billion
Q4 2024

A detailed history of Royal Bank Of Canada transactions in Astrazeneca PLC stock. As of the latest transaction made, Royal Bank Of Canada holds 2,432,811 shares of AZN stock, worth $181 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

2,432,811

Previous 2,491,191 2.34%

Holding current value

$181 Million

Previous $194 Million 17.88%

% of portfolio

0.03%

Previous 0.04%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$63.2 - $79.58 $3.69 Million - $4.65 Million	-58,380 Reduced 2.34%	2,432,811 $159 Million
Q3 2024 Nov 14, 2024	BUY	$76.67 - $87.62 $3.96 Million - $4.53 Million	51,656 Added 2.12%	2,491,191 $194 Million
Q2 2024 Aug 14, 2024	BUY	$66.81 - $80.83 $2.69 Million - $3.25 Million	40,214 Added 1.68%	2,439,535 $190 Million
Q1 2024 Nov 05, 2024	SELL	$61.03 - $69.57 $2.45 Million - $2.8 Million	-40,214 Reduced 1.65%	2,399,321 $163 Million
Q1 2024 May 15, 2024	BUY	$61.03 - $69.57 $2.97 Million - $3.39 Million	48,695 Added 2.07%	2,399,321 $163 Million
Q4 2023 Feb 14, 2024	BUY	$61.89 - $69.28 $2.87 Million - $3.22 Million	46,433 Added 2.02%	2,350,626 $158 Million
Q3 2023 Nov 14, 2023	BUY	$64.85 - $71.7 $4.4 Million - $4.86 Million	67,843 Added 3.03%	2,304,193 $156 Million
Q2 2023 Aug 14, 2023	SELL	$69.91 - $75.81 $4.04 Million - $4.38 Million	-57,826 Reduced 2.52%	2,236,350 $160 Million
Q1 2023 May 15, 2023	BUY	$63.15 - $71.6 $10.3 Million - $11.7 Million	163,722 Added 7.68%	2,294,176 $159 Million
Q4 2022 Feb 14, 2023	SELL	$54.21 - $70.44 $11.1 Million - $14.4 Million	-203,916 Reduced 8.74%	2,130,454 $144 Million
Q3 2022 Nov 14, 2022	SELL	$53.02 - $135.75 $2.33 Million - $5.98 Million	-44,039 Reduced 1.85%	2,334,370 $128 Million
Q2 2022 Aug 15, 2022	SELL	$59.26 - $71.14 $1.75 Million - $2.11 Million	-29,591 Reduced 1.23%	2,378,409 $157 Million
Q1 2022 May 16, 2022	SELL	$55.72 - $67.12 $3.13 Million - $3.77 Million	-56,222 Reduced 2.28%	2,408,000 $160 Million
Q4 2021 Feb 14, 2022	SELL	$54.02 - $63.83 $2.98 Million - $3.52 Million	-55,103 Reduced 2.19%	2,464,222 $144 Million
Q3 2021 Nov 15, 2021	BUY	$55.56 - $60.79 $30.3 Million - $33.2 Million	545,462 Added 27.63%	2,519,325 $151 Million
Q2 2021 Aug 16, 2021	BUY	$48.42 - $60.18 $95.6 Million - $119 Million	1,973,863 New	1,973,863 $118 Million

Others Institutions Holding AZN

# of Institutions

1,356

Shares Held

512M

Call Options Held

6.08M

Put Options Held

4.44M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $230B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Account

Royal Bank Of Canada Astrazeneca PLC Transaction History